Onconetix (ONCO) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Onconetix is the larger company by market cap ($3.4 million vs $439,239), about 7.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ONCO | SXTC |
|---|---|---|
| Share price | $0.6438 | $0.3324 |
| Market cap | $3.37M | $439.24K |
| 1-day change | +7.84% | -88.26% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $310.39 | $-730.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $209.50 | $83,760.00 |
| 52-week low | $0.58 | $0.31 |
| Distance from 52-week high | -99.69% | -100.00% |
| Average volume | 2.23M | 3.73M |
| Shares outstanding | 5.24M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Onconetix is about 7.7 times larger than China SXT Pharmaceuticals by market value ($3.37M vs $439.24K).
ONCO vs SXTC FAQ
Which is bigger, Onconetix or China SXT Pharmaceuticals?
Onconetix (ONCO) is larger, with a market capitalization of $3.37M compared with $439.24K for China SXT Pharmaceuticals (SXTC).
Are Onconetix and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.